Longitudinal analysis reveals improved survival through tailored chemotherapy in metastatic colorectal cancer, highlighting opportunities for individualized patient care.
Multiple agents and combination therapies available to patients with advanced colorectal cancer have significantly improved survival and provided an opportunity for individualization of care, allowing clinicians and patients to prioritize risks and benefits of comparable regimens.
No takes yet. Share an insight, caveat, or question.
Zafar et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: